CD200 is induced by ERK and is a potential therapeutic target in melanoma

Immune-mediated antitumor responses occur in patients with metastatic melanoma (MM), and therapies designed to augment such responses are clinically beneficial. Despite the immunogenicity of melanoma, immunomodulatory therapies fail in the majority of patients with MM. An inability of DCs to suffici...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Petermann, Kimberly B., Rozenberg, Gabriela I., Zedek, Daniel, Groben, Pamela, McKinnon, Karen, Buehler, Christin, Kim, William Y., Shields, Janiel M., Penland, Shannon, Bear, James E., Thomas, Nancy E., Serody, Jonathan S., Sharpless, Norman E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Clinical Investigation 2007
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2075477/
https://ncbi.nlm.nih.gov/pubmed/18008004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI32163
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak